title: Bacterial and human cell mutagenicity study of some C18H10 cyclopenta-fused polycyclic aromatic hydrocarbons associated with fossil fuels combustion.
abstract: A number of isomeric C18H10 polycyclic aromatic hydrocarbons (PAHs), thought to be primarily cyclopenta-fused PAHs, are produced during the combustion and pyrolysis of fossil fuels. To determine the importance of their contributions to the total mutagenic activity of combustion and pyrolysis samples in which they are found, we characterized reference quantities of four C18H10 CP-PAHs: benzo[ghi]fluoranthene (BF), cyclopenta[cd]pyrene (CPP), cyclopent[hi]acephenanthrylene (CPAP), and cyclopent[hi]aceanthrylene (CPAA). Synthesis of CPAA and CPAP is described. The availability of reference samples of these isomers also proved to be an essential aid in the identification of the C18H10 species often found in combustion and pyrolysis samples. Chemical analysis of selected combustion and pyrolysis samples showed that CPP was generally the most abundant C18H10 isomer, followed by CPAP and BF. CPAA was detected only in pyrolysis products from pure PAHs. We tested the four C18H10 PAHs for mutagenicity in a forward mutation assay using S. typhimurium. CPP, BF, and CPAA were roughly twice as mutagenic as benzo[a]pyrene (BaP), whereas CPAP was only slightly active. These PAHs were also tested for mutagenic activity in human cells. In this assay, CPP and CPAA were strongly mutagenic but less active than BaP, whereas CPAP and BF were inactive at the dose levels tested. Also, the bacterial and human cell mutagenicity of CPAA and CPAP were compared with the mutagenicity of their monocyclopenta-fused analogs, aceanthrylene and acephenanthyrlene. Although the mutagenicities of CPAP and acephenanthrylene are similar, the mutagenic activity of CPAA is an order of magnitude greater than that of aceanthyrlene.
authors.affiliation: Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge 02139.
authors.forename: A L
authors.initials: AL
authors.lastname: Lafleur
authors.forename: J P
authors.initials: JP
authors.lastname: Longwell
authors.forename: J A
authors.initials: JA
authors.lastname: Marr
authors.forename: P A
authors.initials: PA
authors.lastname: Monchamp
authors.forename: E F
authors.initials: EF
authors.lastname: Plummer
authors.forename: W G
authors.initials: WG
authors.lastname: Thilly
authors.forename: P P
authors.initials: PP
authors.lastname: Mulder
authors.forename: B B
authors.initials: BB
authors.lastname: Boere
authors.forename: J
authors.initials: J
authors.lastname: Cornelisse
authors.forename: J
authors.initials: J
authors.lastname: Lugtenburg
mesh_terms: D002460:Cell Line; D005579:Fossil Fuels; D006801:Humans; D009152:Mutagenicity Tests; D010084:Oxidation-Reduction; D011083:Polycyclic Compounds / Q000009:adverse effects* / Q000737:chemistry / Q000145:classification; D012486:Salmonella typhimurium / Q000187:drug effects*; D013053:Spectrophotometry
chemical_list: D005579:Fossil Fuels; D011083:Polycyclic Compounds